These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 10657217)

  • 41. Diphtheria-tetanus overimmunization in children with no records: can it be prevented?
    Frank JW; Schabas R; Arshinoff R; Brant R
    CMAJ; 1989 Dec; 141(12):1241-6. PubMed ID: 2590890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Mar; 30(1):23-8. PubMed ID: 9842161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients.
    Krüger S; Müller-Steinhardt M; Kirchner H; Kreft B
    Am J Kidney Dis; 2001 Dec; 38(6):1264-70. PubMed ID: 11728959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Tetanus-diphtheria preventive vaccination: how to proceed when the young child is already "overimmunized"? The Pediatric Vaccination Counseling Service].
    Wiersbitzky S
    Kinderarztl Prax; 1992 Dec; 60(9-10):308-9. PubMed ID: 1289651
    [No Abstract]   [Full Text] [Related]  

  • 47. [Increased level of tetanus antibody twenty one years after a booster dose of tetanus vaccine].
    Geraldes F; Queirós L; Santos MA
    Acta Med Port; 2004; 17(2):183-6. PubMed ID: 15921651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tetanus and diphtheria immunity among females in the United States: are recommendations being followed?
    Kruszon-Moran DM; McQuillan GM; Chu SY
    Am J Obstet Gynecol; 2004 Apr; 190(4):1070-6. PubMed ID: 15118644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seroprotection rate in adults after 1-dose, 2-dose, and 3-dose series of a reduced-diphtheria-tetanus toxoid vaccine (Td) during a diphtheria outbreak in Thailand.
    Suntarattiwong P; Vandepitte WP; Singhamatr P; Chotpitayasunondh T
    Vaccine; 2020 Feb; 38(9):2128-2131. PubMed ID: 31987691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants.
    Puumalainen T; Dagan R; Wuorimaa T; Zeta-Capeding R; Lucero M; Ollgren J; Käyhty H; Nohynek H
    Pediatr Infect Dis J; 2003 Feb; 22(2):141-9. PubMed ID: 12586978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistence of humoral immunity to tetanus and diphtheria in hematopoietic stem cell transplant recipients after post-transplant immunization.
    Škovránková J; Petráš M
    Pediatr Blood Cancer; 2012 Nov; 59(5):908-13. PubMed ID: 22514148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Baseline immunity to diphtheria and immunologic response after booster vaccination with reduced diphtheria and tetanus toxoid vaccine in Thai health care workers.
    Wiboonchutikul S; Manosuthi W; Sangsajja C; Thientong V; Likanonsakul S; Srisopha S; Termvises P; Rujitip J; Loiusirirotchanakul S; Puthavathana P
    Am J Infect Control; 2014 Jul; 42(7):e81-3. PubMed ID: 24751139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intranasal booster vaccination against diphtheria and tetanus in man.
    Aggerbeck H; Gizurarson S; Wantzin J; Heron I
    Vaccine; 1997 Feb; 15(3):307-16. PubMed ID: 9139491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
    Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
    Gupta RK; Griffin P; Rivera R; Siber GR
    Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemic diphtheria in the Kyrgyz Republic, 1994-1998.
    Glinyenko VM; Abdikarimov ST; Firsova SN; Sagamonjan EA; Kadirova R; Nuorti JP; Strebel PM
    J Infect Dis; 2000 Feb; 181 Suppl 1():S98-S103. PubMed ID: 10657199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of vaccination reactions and serologic responses after Td vaccine in pilot studies].
    Kuszewski K; Rymkiewicz D; Zakrzewska A
    Przegl Epidemiol; 1992; 46(4):329-33. PubMed ID: 1305785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of diphtheria convalescent patients to serve as donors for the production of anti-diphtheria immunoglobulin preparations.
    Bissumbhar B; Rakhmanova AG; Berbers GA; Iakolev A; Nosikova E; Melnick O; Ovtcharenko E; Rümke HC; Ruitenberg EJ
    Vaccine; 2004 May; 22(15-16):1886-91. PubMed ID: 15121299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.